Dear cj, Codex is interesting as an example of how our coming world government is planning to operate. With little or no publicity, a remote, corporate-run commission is quietly deciding the rules which will directly effect all of our lives. The whole thing is a stealth operation - at the micro level (these codex regulations) and at the macro level (the installation of a corporate world government). National sovereignty and democracy are being lost - certainly not with a bang, and with scarce few whimpers. Is there anyone from Norway or Germany who can cofirm the status of vitamin availability in those countries currently? -rkm BTW> Note irony re #666 ... the codex of the beast? @@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@ Date: Thu, 24 Apr 1997 To: "Richard K. Moore" <•••@••.•••> From: Andrew Curry <•••@••.•••> Subject: "Special" McLuhan Post -- NOT ARCHIVED Richard, This may be of interest, if you don't see the McLuhan list anyway. Andrew Curry. ------- Forwarded message follows ------- Dear McLuhan Post subscriber, This is a special post, not archived. The topic -- a familiar one to older subscribers -- is the UN "Codex" about to be implementend to BAN VITAMINS in the US, Canada, and other member nations, AS WAS ALREADY DONE IN NORWAY AND GERMANY. The text (below) is taken from the FDA's own website. If you read through the doubletalk, you will find that "harmonizing" with the Codex means simply banning vitamins unless prescribed by a doctor at a cost of maybe 10-20X what vitamins cost now, which is already high. This means that in your ripe old age, dear reader, all that you will be able to rely on for health protection is fresh veggies and the prescription drugs/supplements sparingly issued by the world drug cartels. We are sending this as a Special Post because many of our readers continue to (want to) believe we are crying "wolf" and making this up. We are not. At the end of the message is the address of the only organization in NA totally dedicated to STOPPING THE CODEX. Call or write them . This is YOUR HEALTH on the line. [Instructions on de-listing from this McLuhan List accompany the regular monthly posts, plus are on our site at www.mediaguru.org. Delist instructions sent to our editorial URL, above, will unfortunately be ignored.] -------------------- as received ----- FROM FDA SITE AT http://www.fda.gov/ola/319.htm The regulatory framework administered by the Food and Drug Administration (FDA) to provide public health and safety protection to American consumers is a model that many countries strive to emulate. At the same time, FDA recognizes that we operate in an increasingly more global, more interdependent market environment, and that American consumers can realize significant public health and economic benefits from efforts by FDA to share information, explore opportunities to collaborate on assessments and product reviews, and harmonize standards with its foreign counterparts. Growing demands on FDA's resources to assure the safety and efficacy of greater numbers of increasingly more complex products produced both here and abroad, absolutely mandate that FDA seek ways in which it can share its regulatory workload while maintaining public health protection for American consumers. Science driven harmonization can curtail duplication and thereby significantly reduce the cost of new drug development, in terms of the risks to which patients are exposed, the experimentation with animals, the regulatory costs to government and the cost to industry. For many years, FDA has actively engaged in the kinds of information exchange that lay the foundation for the development and maintenance of high international standards, and pave the way for harmonization activities. We have entered into numerous Memoranda of Understanding (MOU) with other governments to ensure that their products intended for export to the United States adhere to our strict standards of health and safety protection. We also participate in limited and focused education and training initiatives that instruct others in how to conduct their activities so that products shipped to the U.S. will be in accord with U.S. requirements. We exert leadership in a number of international standard-setting organizations. FDA has been a strong supporter of, and participant in, the Codex Alimentarius Commission (Codex). Codex is an international standards-setting organization for food safety composed of national governments from more than 150 countries. The work of Codex is increasingly important with the recognition of Codex as the relevant international standards-setting body for food safety in the Agreement on the Application of Sanitary and Phytosanitary Measures (SPS) resulting from the Uruguay Round of multilateral trade negotiations. Since its inception, Codex has developed in excess of 200 Commodity Standards, more than 40 codes and guidelines, about 2,500 pesticide/commodity maximum limits, and has reviewed the safety of over 500 food additives and contaminants. FDA, through its participation on most Codex Committees, provides scientific and regulatory expertise and forcefully presents U.S. views at the committee meetings. FDA plans to amend its regulations and procedures for consideration of standards adopted by Codex. This action is being taken to provide for the systematic review of the Codex Standards in order to enhance consumer protection, promote international harmonization and fulfill obligations of the United States under international agreements. In recent years, we have put considerable effort into the work of the International Conference on Harmonization (ICH), working closely with our regulatory counterparts in Japan and the European Union, as well as the three areas' organizations representing the major research and development pharmaceutical companies (e.g., the Pharmaceutical Research and Manufacturer's Association (PhRMA)). The goal of ICH is to harmonize across all three regions the requirements for data submitted to support safety, efficacy and quality determinations in new drug applications, and to develop guidelines for the industry based on the harmonized requirements. The past six years of effort have produced over 40 new harmonized guidelines, and another 20 are in various stages of development and review. The ICH effort is one of the best examples of a forward-thinking Agency that is willing to work not only with its regulatory counterparts, but with the regulated industry as well, to develop guidelines harmonized to the highest standards while also eliminating costly duplication of effort. Similar efforts are underway in the areas of medical devices and veterinary drugs. Additionally, for the past three years we have been involved in negotiations to give limited recognition to inspections of drug and device facilities by European Union authorities and to expand the third party device review to include European Union notified bodies. A successful agreement has the potential to save resources for both sides, however, FDA must be satisfied that such an agreement would not compromise our responsibility for protecting American consumers. ****************************************** International Advocates for Health Freedom John C. Hammell, Legislative Advocate 2411 Monroe St.#2 Hollywood, FL 33020 USA 800-333-2553, 954-929-2905, FAX 954-929-0507, FAX ON DEMAND 954-927-8795,•••@••.••• til have own website: http://www.lef.org @@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@ ~=-=-=-=-=-=-=-=~=-=-=-=-=-=-=-=-=~--~=-=-=-=-=-=-=-=-=~=-=-=-=-=-=-=-=-=~ Posted by Richard K. Moore - •••@••.••• - PO Box 26 Wexford, Ireland Cyberlib: ftp://ftp.iol.ie/users/rkmoore/cyberlib | (USA Citizen) * Non-commercial republication encouraged - Please include this sig * * Please Cc: •••@••.••• directly on forwards & replies * ~=-=-=-=-=-=-=-=~=-=-=-=-=-=-=-=-=~--~=-=-=-=-=-=-=-=-=~=-=-=-=-=-=-=-=-=~
Share: